PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Peli BioThermal Engages Rhenus Logistics to Offer 13 New EMEA Crēdo™ on Demand Drop Points

New locations spanning ten European countries further expands return options for growing rental program
 
Peli BioThermal, the global name in temperature controlled packaging, announces 13 new European drop points. The drop points, located within Rhenus Logistics global network, further the expansion of Peli BioThermal’s growing  Cr?do™ on Demand rental program by providing additional points of return for reusable shipping assets.
 
Dominic Hyde, Peli BioThermal’s vice president of Cr?do on Demand, said: “We are delighted to unveil our latest locations serving our Cr?do rental programs which are designed to provide our customers with options. Adding these drop points in key logistics hubs will allow our EMEA customers in pharmaceutical distribution the flexibility and convenience to choose the best drop-off location for their business.”
 
Jonathan Parish, international key account manager at Rhenus Logistics said: “This initiative with Peli BioThermal is another positive demonstration of how the logistics industry has to strategically and transparently collaborate to create unique values in the ever-changing cold chain industry.”
 
Operating worldwide, Rhenus Logistics has a number of GMP and GDP compliant pharmaceutical and healthcare storage warehousing sites in multiple locations throughout Europe offering Peli BioThermal customers a wider service network when transporting pharmaceutical payloads globally.  Located at easy-to-access locations Peli BioThermal’s new drop points provide customers with an additional option for returning Cr?do on Demand assets at the end of the rental period, including Cr?do Xtreme™ pallet shippers and Cr?do™ Cargo bulk shippers. New locations include:

  • Prague Airport (Czech Republic)
  • Copenhagen Airport (Denmark)
  • Lyon Airport (France)
  • Paris Airport (France)
  • Frankfurt Airport (Germany)
  • Munich Airport (Germany)
  • Stuttgart Airport (Germany)
  • Dublin Airport (Ireland)
  • Milan Airport (Italy)
  • Amsterdam Airport (Netherlands)
  • Warsaw Airport (Poland)
  • Zurich Airport (Switzerland)
  • Barcelona Airport (Spain)

 
The new EMEA drop points are among more than 50 global drop points planned for 2018, including additional locations planned for the Americas and Asia. To better support the rapidly expanding Cr?do on Demand program, the company is also expanding the number of network stations in 2018, which act as the origin point for new Cr?do on Demand rental assets, as well as providing services including conditioning and end of rental drop-off. Network stations are often co-locations of Peli BioThermal service centres, which offer conditioning, refurbishment and repair to their line of Credo Cube™ temperature controlled packaging.
 
To learn more about the global network of drop points, service centres and network stations, as well as the wide range of innovative and reliable Peli BioThermal offerings, including Cr?do™ Cargo, Cr?do Xtreme™ and the Cr?do™ on Demand rental program, visit http://pelibiothermal.com.
 
Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026